The Telangana government’s attempts to create a world-class eco system in the life sciences and pharmaceutical sectors are attracting not just new investors, but current enterprises in the city are also declaring massive growth plans.
The United States Pharmacopeia (USP) India revealed its expansion plans in Hyderabad, saying it will invest an extra USD 20 million in a new continuous production (flow chemistry) facility in Genome Valley in Hyderabad.
Pharmaceutical companies would be able to achieve efficiency and flexibility in their manufacturing processes thanks to the facility.
